BMY Earnings
Bristol-Myers Squibb Company next reports earnings on October 29, 2026. Track record: 4/4 beats.
Earnings Reported
October 29, 2026
Current Price
$62.48
EPS Estimate
Earnings Per Share
$1.54
+22.6% YoY
Trailing EPS
Last 12 months earnings
$4.54
Beat Rate
4/4
100%Forward P/E
Price-to-Earnings ratio
9.4
Margin: 18.5%
Analyst Rating
23 analysts
Analyst Sentiment
Buy23 analystsEarnings History
| Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| 2026-09-30 | $1.17 | $1.35 | +14.9% | Beat |
| 2026-06-30 | $1.60 | $2.04 | +27.7% | Beat |
| 2026-03-31 | $1.42 | $1.58 | +11.2% | Beat |
| 2025-12-31 | $1.20 | $1.26 | +4.6% | Beat |
Growth Estimates
| Period | EPS Est. | Revenue Est. | Growth |
|---|---|---|---|
| Current Qtr(0q) | $1.54 | $12.7B | +22.6% |
| Next Qtr(+1q) | $1.50 | $11.1B | -5.4% |
| Current Year(0y) | $6.54 | $50.1B | +6.4% |
| Next Year(+1y) | $6.62 | $48.6B | +1.2% |
Next Quarter Estimates
EPS Estimate
Earnings Per Share
$1.54
Revenue Estimate
$12.7B
Annual EPS Est.
$6.54
+6.4% YoY
BMY Earnings FAQ
When is BMY's next earnings date?
Bristol-Myers Squibb Company (BMY) is expected to report earnings on October 29, 2026. The consensus EPS estimate is $1.54.
Does BMY usually beat earnings estimates?
Bristol-Myers Squibb Company has beaten Wall Street EPS estimates in 4 of the last 4 quarters (100% beat rate).
What is BMY's trailing EPS?
Bristol-Myers Squibb Company's trailing twelve-month EPS is $4.54. This is calculated from the last four quarters of reported earnings.
What do analysts think about BMY?
23 Wall Street analysts cover Bristol-Myers Squibb Company. The consensus rating is "Buy" with an average price target of $65.39, implying 4.7% upside from the current price.